Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa

NCT04143061 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1328

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Immunization
Healthy Volunteers

Interventions

BIOLOGICAL: Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine
BIOLOGICAL: Meningococcal polysaccharide (serogroups A,C,Y and W-135) diphtheria toxoid conjugate vaccine
BIOLOGICAL: Meningococcal polysaccharide (serogroups A, C, Y and W-135) vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company